Beiersdorf Aktiengesellschaft (BEI)
XETRA Stock Exchange · Germany · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 82.14 |
|---|---|
| 52-week range | 67.08 – 110.15 |
| Return, 1 month / 3 months | +7.4% / +4.3% |
| Return, 1 year / 3 years | −13.4% / −30.5% |
| Trend | Uptrend |
| RSI (14) | 68 |
| Volatility (1 year) | 32.2% |
| Worst drawdown (1 year) | -37.8% |
| Average daily value traded | 26.91M EUR |
| Dividend yield | 1.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Beiersdorf is a German consumer goods company based in Hamburg. It makes skin and personal care products, including creams, lotions, cleansers, sun protection and plasters, sold under brands such as NIVEA, Eucerin, La Prairie and Hansaplast. Its customers are everyday consumers around the world, and its products reach them through retail shops, pharmacies and online channels. The company also produces adhesive tapes and industrial adhesive solutions for business customers through its tesa business.
On this site Beiersdorf Aktiengesellschaft appears as a stock on the XETRA Stock Exchange (Germany), code BEI, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Beiersdorf Aktiengesellschaft (BEI) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 82.14 on 22 October 2026.
Its price-based Market X-Ray is 56 out of 100 (a fair price profile), ranking 308 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 13.4% and over the last three months it rose 4.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 49 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 2.6% | ||
| From 52-week high | -25.1% | ||
| Momentum | 57 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 4.3% | ||
| 6-month return | 12.4% | ||
| 12-month return, skipping the last month | -19.4% | ||
| Stability (higher is calmer) | 48 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 32.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -37.8% | ||
| Liquidity | 95 · Strong | Trades actively. | |
| Average daily value traded | 26.91M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 36 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.2% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.7% |
|---|---|
| 1 month | +7.4% |
| 3 months | +4.3% |
| 6 months | +12.4% |
| 1 year | −13.4% |
| 3 years | −30.5% |
| 5 years | −10.7% |
Signals
| 50-day / 200-day average | 77.76 / 80.08 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.43 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Apr 2026 | EUR 1.0000 |
| 22 Apr 2025 | EUR 1.0000 |
| 19 Apr 2024 | EUR 1.0000 |
| 14 Apr 2023 | EUR 0.7000 |
| 19 Apr 2022 | EUR 0.7000 |
| 6 Apr 2021 | EUR 0.7000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.